Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
APEX2 Regulates TERT Expression in Human Embryonic Stem Cell
2026-07-13
This study reveals that APEX2, but not its paralog APEX1, is essential for efficient expression of the TERT gene in human embryonic stem cells. By uncovering APEX2’s unique role in telomerase regulation via chromatin interactions with repetitive DNA, the work advances our understanding of stem cell maintenance and cancer biology.
-
Translational Virology: Advancing Glycan-Targeted EM with 2%
2026-07-13
This thought-leadership article bridges mechanistic insight into coronavirus glycan vulnerabilities with strategic electron microscopy (EM) workflows, highlighting how 2% Phosphotungstic Acid Negative Stain Solution from APExBIO empowers translational researchers to visualize macromolecular targets and optimize antiviral discovery. Integrating landmark glycoprotein findings and competitive landscape analysis, the piece delivers actionable protocol guidance, underscores cross-domain significance, and frames a forward-looking vision for the field.
-
Targeted mRNA Nanoparticles Restore BBB After Ischemic Strok
2026-07-12
This study introduces a lipid nanoparticle system for targeted mRNA delivery to modulate microglia polarization, resulting in blood-brain barrier repair and neuroprotection after ischemic stroke. The approach extends the therapeutic window and demonstrates a feedback mechanism amplifying anti-inflammatory effects in preclinical models.
-
Translational Strategies for Senescent Cell Detection in Inf
2026-07-10
This thought-leadership article explores the mechanistic significance and translational opportunities of high-fidelity senescent cell detection—highlighting APExBIO's Cell Senescence β-Galactosidase Staining Kit—in the context of pathogen-induced inflammatory senescence. It synthesizes emerging findings in immunometabolism, strategic assay design, and workflow optimization, while drawing from the latest research on Treponema pallidum-induced macrophage senescence. The discussion bridges experimental best practices and future clinical translation, offering guidance for researchers in aging, infectious disease, and senolytic drug discovery.
-
Tetrahedral DNA Frameworks Boost Enzymatic Oligonucleotide S
2026-07-09
The referenced study introduces tetrahedral DNA nanostructures (TDNs) as a highly ordered interface to increase the efficiency and accuracy of enzymatic oligonucleotide synthesis (EOS). This approach addresses longstanding limitations of enzyme accessibility and error rates in EOS, with significant implications for DNA data storage and synthetic biology applications.
-
Nilotinib Enhances Anti-PD-L1 Immunotherapy via MHC-I Restor
2026-07-09
Dong et al. uncover a novel immunomodulatory function of nilotinib (AMN-107), demonstrating its ability to upregulate MHC-I expression and synergistically boost anti-PD-L1 therapy efficacy in colorectal cancer models. This mechanistic advance expands the translational relevance of nilotinib beyond kinase inhibition, offering a new strategy to sensitize resistant tumors to immune checkpoint inhibition.
-
Applied Use-Cases of G-1: Selective GPR30 Agonist in Researc
2026-07-08
G-1 (CAS 881639-98-1), a selective GPR30 agonist, empowers precise dissection of rapid estrogen signaling in cardiovascular, cancer, and immunological contexts. This article delivers actionable workflows, troubleshooting strategies, and data-driven insights to maximize reproducibility and interpretive clarity using APExBIO's trusted reagent.
-
HotStart Universal 2X Green qPCR Master Mix: Workflows & Pre
2026-07-08
Harness the HotStart Universal 2X Green qPCR Master Mix for high-specificity, reproducible gene expression analysis—even in complex cancer signaling contexts. This guide details optimized workflows, troubleshooting, and innovative applications, linking bench protocols to translational research breakthroughs.
-
Dorsomorphin 2HCl: Applied AMPK Inhibition in Metabolic Work
2026-07-07
Dorsomorphin 2HCl is a benchmark AMPK inhibitor enabling precise dissection of metabolic and bone morphogenetic pathways in preclinical models. This article delivers actionable protocols, troubleshooting strategies, and evidence-backed insights for applied research in lipid metabolism, osteogenesis, and iron homeostasis.
-
Tetrandrine Alkaloid: Applied Workflows for Ion Channel Rese
2026-07-07
Tetrandrine alkaloid stands out as a robust tool for ion channel modulation, inflammation, and cancer biology research, supported by reproducible workflows and actionable troubleshooting guidance. Discover how optimized protocols and cross-study insights can elevate experimental reliability and unlock new translational opportunities.
-
Nintedanib (BIBF 1120): Precision Angiokinase Inhibition in
2026-07-06
Nintedanib (BIBF 1120) empowers researchers to dissect angiogenesis and fibrotic pathways in robust preclinical models. This guide delivers actionable workflows, protocol optimizations, and troubleshooting strategies—elevating reproducibility in cancer and idiopathic pulmonary fibrosis research.
-
Methotrexate: Mechanistic Rationale and Research Integration
2026-07-06
Methotrexate, a folate antagonist, inhibits dihydrofolate reductase and is widely adopted in immunosuppression and apoptosis research. This review delineates its mechanistic, biophysical, and workflow parameters, clarifying evidence boundaries and protocol best practices.
-
Sorafenib (BAY-43-9006): Workflow Innovations in Cancer Biol
2026-07-05
Sorafenib (BAY-43-9006) stands out as a versatile multikinase inhibitor for dissecting tumor proliferation and angiogenesis, with robust performance in both classic and emerging cancer models. Leveraging recent findings on ATRX-deficient glioma sensitivity, this article delivers protocol enhancements, troubleshooting strategies, and practical insights to unlock Sorafenib’s full potential as a research tool.
-
Methoxy-X04: Redefining Amyloid Beta Fibril Detection in AD
2026-07-04
Explore how Methoxy-X04, a cutting-edge fluorescent amyloid beta probe, uniquely empowers high-contrast, brain-permeable imaging of Aβ pathology in Alzheimer's disease research. This article offers in-depth analysis, protocol guidance, and a practical perspective on integrating Methoxy-X04 into translational workflows.
-
Ceftazidime (SKU B3539): Reliable Solutions for Gram-Negativ
2026-07-03
This article addresses critical challenges in cell viability and infection modeling workflows, focusing on the robust and reproducible performance of Ceftazidime (SKU B3539). Drawing from real laboratory scenarios, it provides evidence-backed strategies for Gram-negative bacterial infection research, with actionable insights tailored for biomedical scientists.